articleTop 1% cited
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Gynecologic Oncology · 2008 · Vol. 112(1) · pp. 40–46
Richard G. Moore✉(Brown University)D. Scott McMeekin(OU Health)Amy Brown(Hartford Hospital)Paul DiSilvestro(Women & Infants Hospital of Rhode Island)Michael Craig MillerW. Jeffrey AllardW GajewskiRobert J. Kurman(Johns Hopkins University)Robert C. Bast(The University of Texas MD Anderson Cancer Center)Steven J. Skates(Harvard University Press)
Ovarian cancer diagnosis and treatmentMicroRNA in disease regulationMedicineLogistic regressionPostmenopausal womenInternal medicineOvarian cancerEpithelial ovarian cancerOncologyCancerGynecology
MeSH terms
AdultAgedAged, 80 and overAlgorithmsFemaleHumansMiddle AgedOvarian NeoplasmsPelvic NeoplasmsPredictive Value of TestsProspective StudiesBiomarkers, TumorLogistic ModelsCA-125 Antigenbeta-Defensins
Funding
- National Cancer Institute
Citations
855
FWCI
32.61
field-weighted impact
References
26
Percentile
100%
vs. same field & year
Citations per year
Cited by
Epithelial ovarian cancer: Evolution of management in the era of precision medicine
CA A Cancer Journal for Clinicians · 2019 · 1,454 citations
CA125 and Ovarian Cancer: A Comprehensive Review
Cancers · 2020 · 584 citations
Prognostic and Diagnostic role of HE4 as a biomarker in ovarian cancer & comparison with CA125 in ovarian cancer patients with their menopausal status
International Journal of Advanced Biochemistry Research · 2022 · 0 citations
References
The CA 125 tumour-associated antigen: a review of the literature
Human Reproduction · 1989 · 973 citations
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma
American Journal of Obstetrics and Gynecology · 1994 · 670 citations
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Gynecologic Oncology · 2007 · 689 citations
A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
BJOG An International Journal of Obstetrics & Gynaecology · 1990 · 956 citations
Survival Impact of Surgical Cytoreduction in Stage IV Epithelial Ovarian Cancer
Gynecologic Oncology · 1999 · 316 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.